Surveillance of patients at high-risk of squamous cell esophageal cancer

详细信息    查看全文

• 作者：A. Chaber-Ciopinska ; MD^a ; ^b ; ^c (PhD Student) ; D. Kiprian ; MD ; PhD^d (Radiotherapy lead at the Institute of Oncology) ; A. Kawecki ; MD ; PhD^d (Head of Department of Head ; Neck Cancer) ; M.F. Kaminski ; MD ; PhD^a ; ^b ; ^c ; ^e ; ^{mfkaminski@coi.waw.pl} (Head of Department of Cancer Prevention)
• 关键词：Esophageal cancer ; Squamous cell carcinoma ; Surveillance ; Achalasia ; Caustic injury ; Tylosis ; Head and neck cancers
• 刊名：Best Practice & Research Clinical Gastroenterology
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：30
• 期：6
• 页码：893-900
• 全文大小：352 K
• 卷排序：30

文摘

Currently curative treatment for esophageal squamous cell cancer (ESCC) is possible only in patients with early-stage, usually asymptomatic disease. In Western countries, where the incidence of ESCC is relatively low, a screening of asymptomatic, average-risk population is untenable. In order to detect early-stage ESCC or its precursor lesions it is important to identify high-risk patients and consider endoscopic surveillance in these groups. These high-risk groups include patients after curative treatment for head and neck cancer, previous endoscopic resection of ESCC, caustic injury, and patients with tylosis or achalasia. This paper discuss the evidence and proposed method of endoscopy surveillance of these high-risk patients.